Vascular Biogenics Ltd. | CIK:0001603207 | 3

  • Filed: 3/15/2018
  • Entity registrant name: Vascular Biogenics Ltd. (CIK: 0001603207)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1603207/000149315218003377/0001493152-18-003377-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1603207/000149315218003377/vblt-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001603207
  • Open this page in separate window: Click
  • ifrs-full:EarningsPerShareExplanatory

    NOTE 13—LOSS PER SHARE

     

    Basic and diluted loss per share:

     

    Basic

     

    Basic loss per share is calculated by dividing the result attributable to equity holders of the Company by the weighted average number of Ordinary Shares in issue during the year.

     

    Diluted

     

    All Ordinary Shares underlying outstanding options, RSU’s and warrants have been excluded from the calculation of the diluted loss per share for the years ended December 31, 2017, 2016 and 2015 since their effect was anti-dilutive. The total number of options, RSU’s and warrants excluded from the calculations of diluted loss per share were – 5,286,095, 4,491,535, and 3,554,179 for the years ended December 31, 2017, 2016 and 2015, respectively.

     

        Year ended December 31  
        2017     2016     2015  
        U.S. dollars in thousands, except per share data  
    Basic and diluted:                        
    Loss attributable to equity holders of the Company   $ 10,138     $ 16,002     $ 14,888  
                             
    Weighted average number of ordinary shares in issue     27,398,169       24,970,585       20,309,596  
                             
    Loss per ordinary share   $ 0.37     $ 0.64     $ 0.73